TY  - GEN
AU  - Shirai,Takao
AU  - Hirose,Takashi
AU  - Noda,Munehide
AU  - Ando,Kouichi
AU  - Ishida,Hiroo
AU  - Hosaka,Takamichi
AU  - Ozawa,Tetsuzi
AU  - Okuda,Kentarou
AU  - Ohnishi,Tsukasa
AU  - Ohmori,Tohru
AU  - Horichi,Naoya
AU  - Adachi,Mitsuru
TI  - Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer
SN  - 0169-5002
PY  - 2006///0921
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Deoxycytidine
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Organoplatinum Compounds
KW  - Retrospective Studies
KW  - Ribonucleotide Reductases
KW  - antagonists & inhibitors
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.lungcan.2006.01.004
ER  -